Clinical trials are human research studies that are used to assess the effectiveness of a medicinal, surgical, or behavioural intervention. They are the most common technique for researchers to determine whether a novel treatment, such as a new medicine, diet, or medical equipment (such as a pacemaker), is safe and effective in humans. A clinical trial is frequently performed to determine whether a new treatment is more successful than the current treatment and/or has fewer negative side effects. Other clinical studies look on techniques to detect a disease early on, sometimes before symptoms appear. Others are experimenting with techniques to avoid a health problem. A clinical study may also look into ways to improve the lives of people who are dealing with a life-threatening illness or a chronic health problem. Caregivers and support groups are sometimes studied in clinical trials.
The goal of mechanistic studies is to learn more about a biological or behavioural process, the pathophysiology of a disease, or the mechanism of action of a treatment. Although not all mechanistic research are clinical trials, a large number of them are. These studies can look at the intervention's mechanisms of action, the causes of different responses, or develop a better knowledge of any potential negative consequences and how they can be mitigated. They may also aid in the understanding of the disease's progression.
Title : Diagnosis and differentiation of lyme disease and tick-borne relapsing fever borreliosis with multiplex line immunoblots
Ranjan Ramasamy, IDFISH Technology, United States
Title : Mast cell degranulation links anti-PEG IgE to anaphylaxis caused by PEGylated drugs and PEG-contained LNP/mRNA COVID vaccines
Zhaohua Zhou, Food and Drug Administration, United States
Title : Genetic factors influencing early immunity to SARS-CoV-2 in the upper respiratory tract
Ranjan Ramasamy, IDFISH Technology, United States
Title : Monoclonal antibodies efficacy in treatment of novel coronavirus infection (COVID-19) in children at risk of developing a severe course of the disease
Ismail Osmanov, Children's city clinical hospital, Russian Federation
Title : Considerations on MS animal modeling: Format of myelin immunogens used for experimental autoimmune encephalomyelitis model establishment may affect pharmacologic responses of anti-inflammatory drugs
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China
Title : Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity
Matthias Hardtke Wolenski, Hannover Medical School, Germany